All In MedTech

Device Trial Radar · NCT06469775

LiSWT for Men With Erectile Dysfunction

Low Intensity Shock Wave Therapy for Men With Mild to Moderate Erectile Dysfunction

Last checked: Nov 19, 2026Latest source record: Apr 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Mar 1, 2025

Primary completion

Sep 1, 2029

Study completion Sep 1, 2031

Sponsor

Lead sponsor
Rutgers, The State University of New JerseyAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 24, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this a clinical trial to investigate the effect of low-intensity shock wave therapy on patients with erectile function. The main questions it aims to answer are: 1. Can low-intensity shock wave therapy (LiSWT) to the penis improve male sexual health, particularly erectile function? 2. What is the optimal LiSWT protocol (number of shocks, energy delivered, timeline, etc) for initial and maintenance therapy? Researchers will compare validated questionnaires on erectile function in men treated with LiSWT compared to men who receive standard of care to see if there is an improvement in erectile function with LiSWT. Participants will be asked to complete questionnaires at each visit. Those who choose to undergo LiSWT will receive 6 sessions, once per week.

Conditions

  • Erectile Dysfunction

Interventions

  • Low intensity shock waveDevice

    6 sessions of low intensity shock wave therapy, applied in 15 minute appointments once weekly.

  • ControlCombination product

    Standard of care treatment: phosphodiesterase 5 inhibitor therapy, vacuum erectile device, constriction bands, intracorporal injections, and penile implant.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sexual Health Inventory for Men (SHIM)Time frame: Performed at baseline, and then at each follow-up appointment (3, 6, 12, 24 months)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Rutgers Robert Wood Johnson Medical School

    New Brunswick, New Jersey

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.